Egg‑based QIVs
FluQuadri® / Vaxigrip Tetra®
NIP funded — cohort‑based
What to know
- QIV only in 2025 (4 strains).
- Funding: NIP for all children 6 months to <5 years, plus First Nations, pregnancy, and eligible medical conditions. Others are private (5–64).
- Dosing first year 6m–<9y: 2 doses ≥4 weeks apart; then 1 dose annually.
- Co‑admin: With COVID‑19; in pregnancy may be co‑given with pertussis (20–32 wks) and maternal RSV (28–36 wks).
- Egg allergy: Not a contraindication. Latex: NIP 2025 flu vaccines are latex‑free.